Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Allen-Auerbach

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 15, 2021
Head-to-Head Comparison of <sup>68</sup>Ga-PSMA-11 PET/CT and mpMRI with a Histopathology Gold Standard in the Detection, Intraprostatic Localization, and Determination of Local Extension of Primary Prostate Cancer: Results from a Prospective Single-Center Imaging TrialIda Sonni, Ely R Felker, Andrew T Lenis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 12, 2026
Phase 2 Prospective Trial of Retreatment with [<sup>177</sup>Lu]Lu-PSMA-617 Molecular Radiotherapy for Metastatic Castration-Resistant Prostate Cancer-RE-LuPSMAJohn Nikitas, Adrien Holzgreve, Jesus Juarez, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 17, 2021
Safety of PSMA-Targeted Molecular Radioligand Therapy with <sup>177</sup>Lu-PSMA-617: Results from the Prospective Multicenter Phase 2 Trial RESIST-PC (NCT03042312)Jeremie Calais, Johannes Czernin, Pan Thin, et al.
Npj Imaging|January 6, 2026
Noninvasive in vivo deoxycytidine kinase (dCK)-PET identifies tumor-draining lymph nodes upon immune checkpoint inhibitor therapyCécile Philippe, Jonathan Cotton, Gregory D Bowden, et al.
Science Translational Medicine|January 20, 2017
Reporter gene imaging of targeted T cell immunotherapy in recurrent gliomaKhun Visith Keu, Timothy H Witney, Shahriar Yaghoubi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 26, 2024
Efficacy and Toxicity of [<sup>177</sup>Lu]Lu-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: Results from the U.S. Expanded-Access Program and Comparisons with Phase 3 VISION DataVishnu Murthy, Andrew F Voter, Kathleen Nguyen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 21, 2021
Prospective phase 2 trial of PSMA-targeted molecular RadiothErapy with <sup>177</sup>Lu-PSMA-617 for metastatic castration-reSISTant Prostate Cancer (RESIST-PC): efficacy results of the UCLA cohortJeremie Calais, Andrei Gafita, Matthias Eiber, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 25, 2023
<sup>68</sup>Ga-FAPI PET/CT Interobserver Agreement on Tumor Assessment: An International Multicenter Prospective StudyRiccardo Mei, Lukas Kessler, Kim M Pabst, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 15, 2017
<sup>68</sup>Ga-PSMA-11 PET/CT Interobserver Agreement for Prostate Cancer Assessments: An International Multicenter Prospective StudyWolfgang Peter Fendler, Jeremie Calais, Martin Allen-Auerbach, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 12, 2025
<sup>177</sup>Lu-Prostate-Specific Membrane Antigen Neoadjuvant to Stereotactic Ablative Radiotherapy for Oligorecurrent Prostate Cancer (LUNAR): An Open-Label, Randomized, Controlled, Phase II StudyAmar U Kishan, Luca F Valle, Holly Wilhalme, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 15, 2021
Head-to-Head Comparison of <sup>68</sup>Ga-PSMA-11 PET/CT and mpMRI with a Histopathology Gold Standard in the Detection, Intraprostatic Localization, and Determination of Local Extension of Primary Prostate Cancer: Results from a Prospective Single-Center Imaging TrialIda Sonni, Ely R Felker, Andrew T Lenis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 12, 2026
Phase 2 Prospective Trial of Retreatment with [<sup>177</sup>Lu]Lu-PSMA-617 Molecular Radiotherapy for Metastatic Castration-Resistant Prostate Cancer-RE-LuPSMAJohn Nikitas, Adrien Holzgreve, Jesus Juarez, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 17, 2021
Safety of PSMA-Targeted Molecular Radioligand Therapy with <sup>177</sup>Lu-PSMA-617: Results from the Prospective Multicenter Phase 2 Trial RESIST-PC (NCT03042312)Jeremie Calais, Johannes Czernin, Pan Thin, et al.
Npj Imaging|January 6, 2026
Noninvasive in vivo deoxycytidine kinase (dCK)-PET identifies tumor-draining lymph nodes upon immune checkpoint inhibitor therapyCécile Philippe, Jonathan Cotton, Gregory D Bowden, et al.
Science Translational Medicine|January 20, 2017
Reporter gene imaging of targeted T cell immunotherapy in recurrent gliomaKhun Visith Keu, Timothy H Witney, Shahriar Yaghoubi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 26, 2024
Efficacy and Toxicity of [<sup>177</sup>Lu]Lu-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: Results from the U.S. Expanded-Access Program and Comparisons with Phase 3 VISION DataVishnu Murthy, Andrew F Voter, Kathleen Nguyen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 21, 2021
Prospective phase 2 trial of PSMA-targeted molecular RadiothErapy with <sup>177</sup>Lu-PSMA-617 for metastatic castration-reSISTant Prostate Cancer (RESIST-PC): efficacy results of the UCLA cohortJeremie Calais, Andrei Gafita, Matthias Eiber, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 25, 2023
<sup>68</sup>Ga-FAPI PET/CT Interobserver Agreement on Tumor Assessment: An International Multicenter Prospective StudyRiccardo Mei, Lukas Kessler, Kim M Pabst, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 15, 2017
<sup>68</sup>Ga-PSMA-11 PET/CT Interobserver Agreement for Prostate Cancer Assessments: An International Multicenter Prospective StudyWolfgang Peter Fendler, Jeremie Calais, Martin Allen-Auerbach, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 12, 2025
<sup>177</sup>Lu-Prostate-Specific Membrane Antigen Neoadjuvant to Stereotactic Ablative Radiotherapy for Oligorecurrent Prostate Cancer (LUNAR): An Open-Label, Randomized, Controlled, Phase II StudyAmar U Kishan, Luca F Valle, Holly Wilhalme, et al.
Pageof 5